Regenacy Pharmaceuticals Demonstrates Reversal of Chemotherapy-Induced Peripheral Neuropathy with HDAC6 Inhibitor Ricolinostat in Preclinical Model
BioMed Reports,
-- Results from Preclinical Studies of Selective HDAC6 Inhibitors Published Online in PAIN – BOSTON--( BUSINESS WIRE )-…